Eric R Powers
Overview
Explore the profile of Eric R Powers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shcherbakov-Wu W, Saris S, Sheehan T, Wong N, Powers E, Krieg F, et al.
Sci Adv
. 2024 Feb;
10(8):eadj2630.
PMID: 38381813
In semiconductors, exciton or charge carrier diffusivity is typically described as an inherent material property. Here, we show that the transport of excitons among CsPbBr perovskite nanocrystals (NCs) depends markedly...
2.
Lee W, Cho Y, Powers E, Paritmongkol W, Sakurada T, Kulik H, et al.
ACS Nano
. 2022 Nov;
16(12):20318-20328.
PMID: 36416726
Silver phenylselenolate (AgSePh, also known as "mithrene") and silver phenyltellurolate (AgTePh, also known as "tethrene") are two-dimensional (2D) van der Waals semiconductors belonging to an emerging class of hybrid organic-inorganic...
3.
Ha S, Shcherbakov-Wu W, Powers E, Paritmongkol W, Tisdale W
ACS Nano
. 2021 Nov;
15(12):20527-20538.
PMID: 34793677
Substitutional metal doping is a powerful strategy for manipulating the emission spectra and excited state dynamics of semiconductor nanomaterials. Here, we demonstrate the synthesis of colloidal manganese (Mn)-doped organic-inorganic hybrid...
4.
Viray M, Bonno E, Gabrielle N, Maron B, Atkins J, Amoroso N, et al.
Circ Heart Fail
. 2020 Oct;
13(11):e007981.
PMID: 33016102
No abstract available.
5.
Paritmongkol W, Powers E, Dahod N, Tisdale W
J Phys Chem Lett
. 2020 Sep;
11(20):8565-8572.
PMID: 32975424
Broadband emission in lead iodide 2D perovskites has been alternately attributed to self-trapped excitons (STEs) or permanent structural defects and/or impurities. Here, we investigate six different multilayered ( > 1)...
6.
7.
Yamamoto M, Maehara A, Stone G, Kini A, Brilakis E, Rizik D, et al.
J Am Coll Cardiol
. 2020 Mar;
75(12):1371-1382.
PMID: 32216905
Background: Autopsy studies suggest that implanting stents in lipid-rich plaque (LRP) may be associated with adverse outcomes. Objectives: The purpose of this study was to evaluate the association between LRP...
8.
Houston B, Tedford R, Baxley R, Sykes B, Powers E, Nielsen C, et al.
Am J Cardiol
. 2019 Jul;
124(5):756-762.
PMID: 31296367
Lymphatic flow is augmented in states of chronic heart failure (cHF). However, the biological mechanism driving increased lymphatic flow capacity (lymphangiogenesis) in cHF is unknown. Recent studies have indicated that...
9.
Floroff C, Palm N, Steinberg D, Powers E, Wiggins B
Pharmacotherapy
. 2017 Jan;
37(4):393-400.
PMID: 28107569
Study Objective: To evaluate the time to achieve therapeutic activated partial thromboplastin time (aPTT) values and occurrence of bleeding based on standard unfractionated heparin (UFH) weight-based dosing recommendations compared with...
10.